Header Logo

Connection

Ralf Janknecht to Carcinoma, Hepatocellular

Back to Details
This is a "connection" page, showing publications Ralf Janknecht has written about Carcinoma, Hepatocellular.
Ralf Janknecht
Connection Strength
0.025
Carcinoma, Hepatocellular
  1. Fluvastatin interferes with hepatitis C virus replication via microtubule bundling and a doublecortin-like kinase-mediated mechanism. PLoS One. 2013; 8(11):e80304.
    View in: PubMed
    Score: 0.025
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.